"Antimanic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that are used to treat bipolar disorders or mania associated with other affective disorders.
| Descriptor ID |
D018692
|
| MeSH Number(s) |
D27.505.696.277.950.025 D27.505.954.427.210.950.025 D27.505.954.427.700.872.025
|
| Concept/Terms |
Antimanic Agents- Antimanic Agents
- Agents, Antimanic
- Antimanic Drugs
- Drugs, Antimanic
- Antimanics
Antimanic Effect- Antimanic Effect
- Effect, Antimanic
- Antimanic Effects
- Effects, Antimanic
|
Below are MeSH descriptors whose meaning is more general than "Antimanic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antimanic Agents".
This graph shows the total number of publications written about "Antimanic Agents" by people in this website by year, and whether "Antimanic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2006 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antimanic Agents" by people in Profiles.
-
The chronotherapeutic treatment of bipolar disorders: A systematic review and practice recommendations from the ISBD task force on chronotherapy and chronobiology. Bipolar Disord. 2019 12; 21(8):741-773.
-
Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania. J Psychiatr Res. 2012 Dec; 46(12):1564-8.
-
Early improvement with lithium in classic mania and its association with later response. J Affect Disord. 2013 Jan 10; 144(1-2):160-4.
-
Older adults with bipolar disorder: guidelines for primary care providers. J Gerontol Nurs. 2010 May; 36(5):20-7; quiz 28-9.
-
Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology. 2010 Mar; 35(4):990-8.
-
Calming the bipolar storm: treating acute mania and mixed episodes in patients with bipolar disorder. CNS Spectr. 2006 Nov; 11(11 Suppl 13):1-11; discussion 12-3; quiz 14-6.
-
Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder. J Clin Psychopharmacol. 2006 Aug; 26(4):444-6.
-
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol. 2004 Oct; 24(5):512-20.
-
Biochemical and psychiatric predictors of Li(+) response and toxicity in Li(+)-treated bipolar patients. Bipolar Disord. 2004 Feb; 6(1):53-61.
-
Valproic acid for the treatment of social anxiety disorder. Int Clin Psychopharmacol. 2003 May; 18(3):169-72.